Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Mol Metab ; 78: 101813, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37777008

ABSTRACT

OBJECTIVE: Hepatic steatosis is a key initiating event in the pathogenesis of alcohol-associated liver disease (ALD), the most detrimental organ damage resulting from alcohol use disorder. However, the mechanisms by which alcohol induces steatosis remain incompletely understood. We have previously found that alcohol binging impairs brain insulin action, resulting in increased adipose tissue lipolysis by unrestraining sympathetic nervous system (SNS) outflow. Here, we examined whether an impaired brain-SNS-adipose tissue axis drives hepatic steatosis through unrestrained adipose tissue lipolysis and increased lipid flux to the liver. METHODS: We examined the role of lipolysis, and the brain-SNS-adipose tissue axis and stress in alcohol induced hepatic triglyceride accumulation in a series of rodent models: pharmacological inhibition of the negative regulator of insulin signaling protein-tyrosine phosphatase 1ß (PTP1b) in the rat brain, tyrosine hydroxylase (TH) knockout mice as a pharmacogenetic model of sympathectomy, adipocyte specific adipose triglyceride lipase (ATGL) knockout mice, wildtype (WT) mice treated with ß3 adrenergic agonist or undergoing restraint stress. RESULTS: Intracerebral administration of a PTP1b inhibitor, inhibition of adipose tissue lipolysis and reduction of sympathetic outflow ameliorated alcohol induced steatosis. Conversely, induction of adipose tissue lipolysis through ß3 adrenergic agonism or by restraint stress worsened alcohol induced steatosis. CONCLUSIONS: Brain insulin resistance through upregulation of PTP1b, increased sympathetic activity, and unrestrained adipose tissue lipolysis are key drivers of alcoholic steatosis. Targeting these drivers of steatosis may provide effective therapeutic strategies to ameliorate ALD.


Subject(s)
Fatty Liver, Alcoholic , Fatty Liver , Liver Diseases, Alcoholic , Rats , Mice , Animals , Lipolysis , Rodentia/metabolism , Fatty Liver/pathology , Insulin/metabolism , Ethanol/adverse effects , Mice, Knockout , Obesity
2.
Front Pediatr ; 10: 906379, 2022.
Article in English | MEDLINE | ID: mdl-35923781

ABSTRACT

Objective: This study aimed to investigate neonatal sepsis as potential risk factor for adverse behavioral outcome in very low birth weight infants (VLBWI) at preschool age. Regardless of improvements in the obstetric and neonatal intensive care, preterm infants are still at high risk for behavioral problems later in life. The spectrum, origin and potential risk factors of these behavioral problems have not been well-defined. Methods: In this retrospective observational study, the influence of culture-proven neonatal sepsis on the behavioral outcome of VLBWI born at a gestational age <32 weeks was analyzed at 5 years of age in a multivariable regression model. Behavior was assessed with the Child Behavior Checklist (CBCL). Neonatal morbidities, socioeconomic status and neurodevelopmental outcome served as covariates in the analysis. Results: 312 VLBWI entered the final analysis, of whom 11% had experienced neonatal sepsis. Neonatal sepsis appeared to be a relevant risk factor for both internalizing, i.e., emotional reactivity and anxiety/depression, as well as externalizing behavioral problems, i.e., oppositional and aggressive behavior in this cohort of VLBWI. Low socioeconomic status and male gender were additional statistically significant risk factors for both internalizing and externalizing behavioral problems. No difference in neurocognitive development was observed between the groups. Conclusion: The study supports the fact that VLBWI are vulnerable to multiple behavioral disorders independent of their cognitive development. In contrast to former assumptions, the results of the study emphasize that not only post-natal environment but also neonatal morbidities, especially neonatal sepsis, have an impact on behavioral outcome of VLBWI at preschool age.

3.
Acta Paediatr ; 110(8): 2359-2365, 2021 08.
Article in English | MEDLINE | ID: mdl-33955057

ABSTRACT

Data evaluating mortality and morbidity in infants born ≤500 g are scarce and show wide variability. To support counselling and decision-making, we analysed neurodevelopmental outcome in all neonates ≤500 g birth weight. Retrospective analysis including preterm infants with a birth weight ≤500 g and a gestational age >22 weeks born at a single tertiary perinatal centre between 2010 and 2017. Of 59 live births, 88% received standard care. Birth weight ranged from 318 to 500 g and gestational age from 23 to 29 weeks. 56% of neonates were born ≤3rd percentile and 42% of treated infants survived. Neurodevelopmental outcome was available in 91% of patients and was evaluated using Bayley Scales of Infant Development at two years. 50% showed a favourable mental development (normal or mild impairment), 75% a favourable motor development and 45% a favourable outcome in both outcome subcategories. When additionally considering visual and hearing disability and, or, cerebral palsy level ≥2 according to the Gross Motor Function Classification System 35% had a good neurodevelopmental outcome. Survival rate was 37% for all live births and 42% for infants with standard care. More than one-third of survivors showed no significant neurodevelopmental impairment at two years.


Subject(s)
Infant, Extremely Premature , Infant, Premature, Diseases , Child , Female , Gestational Age , Humans , Infant , Infant Mortality , Infant, Newborn , Infant, Premature, Diseases/epidemiology , Morbidity , Pregnancy , Retrospective Studies
4.
Cells ; 9(4)2020 04 22.
Article in English | MEDLINE | ID: mdl-32331397

ABSTRACT

Maternal immune activation (MIA) during pregnancy impacts offspring neurodevelopmental trajectories and induces lifelong consequences, including emotional and cognitive alterations. Using the polyinosinic:polycytidilic acid (PIC) MIA model we have previously demonstrated enhanced depression-like behavior in adult MIA offspring, which was associated with reduced expression of the vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) in the hippocampus. Since VEGF mediates the effects of various antidepressant agents, we here set out to explore whether VEGF administration could rescue the depression-like behavioral deficits in MIA offspring. To test our hypothesis, control and MIA offspring were intracerebroventricularly (i.c.v.) infused with either VEGF or vehicle solution and depression-related behavior was assessed in the sucrose preference test (SPT) and the tail suspension test (TST). As a surrogate of VEGF activity, the phosphorylation of the extracellular signal-regulated kinase (ERK) in hippocampus was quantified. We found that VEGF treatment reduced depression-related behavioral despair in the TST in MIA offspring but had no effect on anhedonia-like behavior in the SPT. While VEGF administration induced the phosphorylation of ERK in the hippocampus of control offspring, this effect was blunted in the MIA offspring. We conclude that VEGF administration, at the dosage tested, beneficially affects some aspects of the depression-like phenotype in the adult MIA offspring, inviting further studies using different dosage regimes to further explore the therapeutic potential of VEGF treatment in MIA-related changes in brain function and behavior.


Subject(s)
Behavior, Animal , Depression/drug therapy , Prenatal Exposure Delayed Effects/pathology , Vascular Endothelial Growth Factor A/therapeutic use , Animals , Extracellular Signal-Regulated MAP Kinases/metabolism , Female , Hippocampus/metabolism , Male , Mice, Inbred C57BL , Phosphorylation , Pregnancy , Signal Transduction , Vascular Endothelial Growth Factor A/administration & dosage
5.
Neonatology ; 114(2): 149-154, 2018.
Article in English | MEDLINE | ID: mdl-29895034

ABSTRACT

BACKGROUND: Clostridium difficile is a gram-positive, anaerobic spore-forming, toxin-producing bacillus, which is one of the most common causes for health care-associated infections. High colonization rates in clinically asymptomatic neonates and infants have been described, although most studies go back to the early 1980 and 1990s, and were carried out in term and late preterm infants. OBJECTIVES: The aim of our study was to determine both the impact and time course of C. difficile colonization in a cohort of very low birth weight infants (VLBWI) in an era of PCR-based technologies for diagnosis. METHODS: Stool samples of VLBWI were analyzed for the presence of C. difficile strains in regular intervals during the hospital stay by PCR ribotyping. Analysis was continued throughout the first 2 years of life. RESULTS: A 32% C. difficile colonization rate during the first 2 years of life and an in-hospital colonization rate of 8% was found in a cohort of 190 VLBWI. C. difficile colonization occurred mainly in the first 6 months of life, which was similar to term neonates. In-hospital colonization accounted for only a small percentage of cases with no detection of hypervirulent strains. Also, C. difficile colonization was not related to an adverse outcome in this VLBWI cohort. Oral lactoferrin of bovine origin and treatment with piperacillin/tazobactam were negatively correlated with C. difficile colonization in our study. CONCLUSIONS: C. difficile colonization in our cohort of VLBWI was significantly lower than has been described in the literature and was not related to an adverse outcome.


Subject(s)
Clostridioides difficile/isolation & purification , Clostridium Infections/epidemiology , Feces/microbiology , Infant, Very Low Birth Weight , Austria/epidemiology , Clostridioides difficile/genetics , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Infant, Premature , Male , Tertiary Care Centers , Time Factors
6.
J Obstet Gynecol Neonatal Nurs ; 46(5): 748-754, 2017.
Article in English | MEDLINE | ID: mdl-28710905

ABSTRACT

OBJECTIVE: To evaluate the acceptance, adherence, and feasibility of fortifier administration by finger feeder during breastfeeding and to determine weight, length, and head circumference gains after discharge for preterm infants. DESIGN: Observational pilot study. SETTING: A Level III NICU and its outpatient clinic in Vienna, Austria. PARTICIPANTS: Infants born at younger than 34 weeks gestation were included. METHODS: Mothers were screened in a tertiary NICU and trained by certified lactation consultants to administer fortifier with a finger feeder during breastfeeding. Data on finger feeder use at home were collected by self-reported feeding diaries and questionnaires. RESULTS: In total, data from 24 mother-infant dyads were analyzed. The acceptance rate was 67%. In 41.7%, more than 50% of meals were fortified. Mothers did not report problems in preparation, but 33% of the infants stopped latching on or drooled milk during finger feeder use. CONCLUSION: Use of a finger feeder to administer fortifier to preterm infants enabled mothers to exclusively breastfeed their infants and meet their nutritional needs. The development of further methods to augment preterm infant nutrition that do not interfere with breastfeeding is of great interest.


Subject(s)
Breast Feeding/methods , Feeding Methods/instrumentation , Food, Fortified , Infant, Premature , Patient Discharge , Adult , Body Weight , Equipment Design , Female , Gestational Age , Humans , Infant, Newborn , Infant, Premature/growth & development , Infant, Premature/physiology , Male , Nutritional Requirements , Outcome Assessment, Health Care , Weight Gain
7.
Diabetes ; 66(6): 1560-1571, 2017 06.
Article in English | MEDLINE | ID: mdl-28385803

ABSTRACT

Insulin is a key regulator of adipose tissue lipolysis, and impaired adipose tissue insulin action results in unrestrained lipolysis and lipotoxicity, which are hallmarks of the metabolic syndrome and diabetes. Insulin regulates adipose tissue metabolism through direct effects on adipocytes and through signaling in the central nervous system by dampening sympathetic outflow to the adipose tissue. Here we examined the role of insulin signaling in agouti-related protein (AgRP) and pro-opiomelanocortin (POMC) neurons in regulating hepatic and adipose tissue insulin action. Mice lacking the insulin receptor in AgRP neurons (AgRP IR KO) exhibited impaired hepatic insulin action because the ability of insulin to suppress hepatic glucose production (hGP) was reduced, but the ability of insulin to suppress lipolysis was unaltered. To the contrary, in POMC IR KO mice, insulin lowered hGP but failed to suppress adipose tissue lipolysis. High-fat diet equally worsened glucose tolerance in AgRP and POMC IR KO mice and their respective controls but increased hepatic triglyceride levels only in POMC IR KO mice, consistent with impaired lipolytic regulation resulting in fatty liver. These data suggest that although insulin signaling in AgRP neurons is important in regulating glucose metabolism, insulin signaling in POMC neurons controls adipose tissue lipolysis and prevents high-fat diet-induced hepatic steatosis.


Subject(s)
Adipose Tissue/metabolism , Agouti-Related Protein/metabolism , Glucose/metabolism , Insulin/metabolism , Liver/metabolism , Neurons/metabolism , Pro-Opiomelanocortin/metabolism , Receptor, Insulin/genetics , Adipose Tissue/drug effects , Animals , Calorimetry, Indirect , Cold Temperature , Diet, High-Fat , Enzyme-Linked Immunosorbent Assay , Fatty Liver/metabolism , Glucose Clamp Technique , Glucose Tolerance Test , Hypoglycemic Agents/pharmacology , Hypothalamus/cytology , Hypothalamus/metabolism , Insulin/pharmacology , Lipolysis , Mice , Mice, Knockout , Real-Time Polymerase Chain Reaction , Receptor, Insulin/metabolism , Signal Transduction , Triglycerides/metabolism
8.
Brain Behav Immun ; 63: 127-136, 2017 Jul.
Article in English | MEDLINE | ID: mdl-27765645

ABSTRACT

Gestational infection is increasingly being recognized for its involvement as causative mechanism in severe developmental brain abnormalities and its contribution to the pathogenesis of psychopathologies later in life. First observations in the widely accepted maternal immune activation (MIA) model based upon the systemic administration of the viral mimetic Polyinosinic:polycytidylic acid (poly(I:C)) have recently suggested a transmission of behavioral and transcriptional traits across generations. Although maternal care behavior (MCB) is known as essential mediator of the transgenerational effects of environmental challenges on offspring brain function and behavior, the possible propagation of alterations of MCB resulting from MIA to following generations has not yet been examined. Here we show that poly(I:C) stimulation at embryonic day 12.5 (E12.5) leads to aberrant MCB and that this effect is transmitted to the female F1 offspring. The transgenerational effects on MCB are paralleled by enhanced depression-like behavior in the second generation F2 offspring with contributions of both maternal and paternal heritages. Examination of offspring hippocampal expression of genes known as targets of MCB and relevant for ensuing non-genetic transmission of altered brain function and behavior revealed transgenerationally conserved and modified expressional patterns in the F1 and F2 generation. Collectively these data firstly demonstrate the transgenerational transmission of the impact of gestational immune activation on the reproductive care behavior of the mother. Behavioral and molecular characteristics of first and second generation offspring suggest transgenerationally imprinted consequences of gestational infection on psychopathological traits related to mood disorders which remain to be examined in future cross-fostering experiments.


Subject(s)
Depression/immunology , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Brain Diseases , Cytokines/immunology , Depressive Disorder/immunology , Disease Models, Animal , Family Characteristics , Female , Gene-Environment Interaction , Male , Maternal Behavior/physiology , Maternal Exposure/adverse effects , Mice , Mice, Inbred C57BL , Poly I-C/pharmacology , Pregnancy , Prenatal Exposure Delayed Effects/immunology
9.
Alzheimers Dement ; 12(8): 851-61, 2016 08.
Article in English | MEDLINE | ID: mdl-26928090

ABSTRACT

INTRODUCTION: Epidemiologic studies have demonstrated an association between diabetes and dementia. Insulin signaling within the brain, in particular within the hypothalamus regulates carbohydrate, lipid, and branched chain amino acid (BCAA) metabolism in peripheral organs such as the liver and adipose tissue. We hypothesized that cerebral amyloidosis impairs central nervous system control of metabolism through disruption of insulin signaling in the hypothalamus, which dysregulates glucose and BCAA homeostasis resulting in increased susceptibility to diabetes. METHODS: We examined whether APP/PS1 mice exhibit increased susceptibility to aging or high-fat diet (HFD)-induced metabolic impairment using metabolic phenotyping and insulin-signaling studies. RESULTS: APP/PS1 mice were more susceptible to high-fat feeding and aging-induced metabolic dysregulation including disrupted BCAA homeostasis and exhibited impaired hypothalamic insulin signaling. DISCUSSION: Our data suggest that AD pathology increases susceptibility to diabetes due to impaired hypothalamic insulin signaling, and that plasma BCAA levels could serve as a biomarker of hypothalamic insulin action in patients with AD.


Subject(s)
Alzheimer Disease/complications , Alzheimer Disease/pathology , Amino Acids, Branched-Chain/metabolism , Hypothalamus/metabolism , Insulin/metabolism , Metabolic Diseases/etiology , Signal Transduction/physiology , Alzheimer Disease/genetics , Amino Acids, Branched-Chain/blood , Amyloid beta-Protein Precursor/genetics , Animals , Body Weight/genetics , Diet, High-Fat/adverse effects , Disease Models, Animal , Eating/genetics , Gene Expression Regulation/genetics , Humans , Hypothalamus/physiopathology , Insulin Resistance/genetics , Male , Mice , Mice, Transgenic , Mutation/genetics , Presenilin-1/genetics , Triglycerides/metabolism
10.
Diabetes ; 65(6): 1511-20, 2016 06.
Article in English | MEDLINE | ID: mdl-26861781

ABSTRACT

Hepatic steatosis is common in obesity and insulin resistance and results from a net retention of lipids in the liver. A key mechanism to prevent steatosis is to increase secretion of triglycerides (TG) packaged as VLDLs. Insulin controls nutrient partitioning via signaling through its cognate receptor in peripheral target organs such as liver, muscle, and adipose tissue and via signaling in the central nervous system (CNS) to orchestrate organ cross talk. While hepatic insulin signaling is known to suppress VLDL production from the liver, it is unknown whether brain insulin signaling independently regulates hepatic VLDL secretion. Here, we show that in conscious, unrestrained male Sprague Dawley rats the infusion of insulin into the third ventricle acutely increased hepatic TG secretion. Chronic infusion of insulin into the CNS via osmotic minipumps reduced the hepatic lipid content as assessed by noninvasive (1)H-MRS and lipid profiling independent of changes in hepatic de novo lipogenesis and food intake. In mice that lack the insulin receptor in the brain, hepatic TG secretion was reduced compared with wild-type littermate controls. These studies identify brain insulin as an important permissive factor in hepatic VLDL secretion that protects against hepatic steatosis.


Subject(s)
Brain/metabolism , Insulin/physiology , Liver/metabolism , Signal Transduction/physiology , Triglycerides/metabolism , Animals , Fatty Liver/physiopathology , Lipoproteins, VLDL/metabolism , Male , Mice , Rats , Rats, Sprague-Dawley
11.
Mol Cell ; 57(1): 69-82, 2015 Jan 08.
Article in English | MEDLINE | ID: mdl-25482509

ABSTRACT

Proapoptotic BCL-2 proteins converge upon the outer mitochondrial membrane (OMM) to promote mitochondrial outer membrane permeabilization (MOMP) and apoptosis. Here we investigated the mechanistic relationship between mitochondrial shape and MOMP and provide evidence that BAX requires a distinct mitochondrial size to induce MOMP. We utilized the terminal unfolded protein response pathway to systematically define proapoptotic BCL-2 protein composition after stress and then directly interrogated their requirement for a productive mitochondrial size. Complementary biochemical, cellular, in vivo, and ex vivo studies reveal that Mfn1, a GTPase involved in mitochondrial fusion, establishes a mitochondrial size that is permissive for proapoptotic BCL-2 family function. Cells with hyperfragmented mitochondria, along with size-restricted OMM model systems, fail to support BAX-dependent membrane association and permeabilization due to an inability to stabilize BAXα9·membrane interactions. This work identifies a mechanistic contribution of mitochondrial size in dictating BAX activation, MOMP, and apoptosis.


Subject(s)
GTP Phosphohydrolases/genetics , Mitochondria, Liver/genetics , Mitochondrial Membranes/metabolism , Organelle Shape/genetics , bcl-2-Associated X Protein/genetics , Animals , Apoptosis , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Bcl-2-Like Protein 11 , GTP Phosphohydrolases/metabolism , Gene Expression Regulation , Membrane Potential, Mitochondrial/genetics , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Mitochondria, Liver/metabolism , Mitochondria, Liver/ultrastructure , Mitochondrial Dynamics/genetics , Mitochondrial Membranes/ultrastructure , Permeability , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Signal Transduction , Unilamellar Liposomes/chemistry , Unilamellar Liposomes/metabolism , bcl-2 Homologous Antagonist-Killer Protein/genetics , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-2-Associated X Protein/metabolism
12.
Cell Metab ; 20(5): 898-909, 2014 Nov 04.
Article in English | MEDLINE | ID: mdl-25307860

ABSTRACT

Circulating branched-chain amino acid (BCAA) levels are elevated in obesity/diabetes and are a sensitive predictor for type 2 diabetes. Here we show in rats that insulin dose-dependently lowers plasma BCAA levels through induction of hepatic protein expression and activity of branched-chain α-keto acid dehydrogenase (BCKDH), the rate-limiting enzyme in the BCAA degradation pathway. Selective induction of hypothalamic insulin signaling in rats and genetic modulation of brain insulin receptors in mice demonstrate that brain insulin signaling is a major regulator of BCAA metabolism by inducing hepatic BCKDH. Short-term overfeeding impairs the ability of brain insulin to lower BCAAs in rats. High-fat feeding in nonhuman primates and obesity and/or diabetes in humans is associated with reduced BCKDH protein in liver. These findings support the concept that decreased hepatic BCKDH is a major cause of increased plasma BCAAs and that hypothalamic insulin resistance may account for impaired BCAA metabolism in obesity and diabetes.


Subject(s)
Amino Acids, Branched-Chain/blood , Brain/metabolism , Insulin/metabolism , Liver/metabolism , 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)/metabolism , Amino Acids, Branched-Chain/metabolism , Animals , Caenorhabditis elegans , Diabetes Mellitus, Type 2/metabolism , Diet, High-Fat/adverse effects , Hyperglycemia/blood , Hyperglycemia/metabolism , Male , Mice , Obesity/metabolism , Rats , Rats, Sprague-Dawley , Signal Transduction
13.
PLoS One ; 9(7): e103337, 2014.
Article in English | MEDLINE | ID: mdl-25076055

ABSTRACT

Dichlorodiphenyltrichloroethane (DDT) has been used extensively to control malaria, typhus, body lice and bubonic plague worldwide, until countries began restricting its use in the 1970s. Its use in malaria control continues in some countries according to recommendation by the World Health Organization. Individuals exposed to elevated levels of DDT and its metabolite dichlorodiphenyldichloroethylene (DDE) have an increased prevalence of diabetes and insulin resistance. Here we hypothesize that perinatal exposure to DDT disrupts metabolic programming leading to impaired metabolism in adult offspring. To test this, we administered DDT to C57BL/6J mice from gestational day 11.5 to postnatal day 5 and studied their metabolic phenotype at several ages up to nine months. Perinatal DDT exposure reduced core body temperature, impaired cold tolerance, decreased energy expenditure, and produced a transient early-life increase in body fat in female offspring. When challenged with a high fat diet for 12 weeks in adulthood, female offspring perinatally exposed to DDT developed glucose intolerance, hyperinsulinemia, dyslipidemia, and altered bile acid metabolism. Perinatal DDT exposure combined with high fat feeding in adulthood further impaired thermogenesis as evidenced by reductions in core temperature and in the expression of numerous RNA that promote thermogenesis and substrate utilization in the brown adipose tissue of adult female mice. These observations suggest that perinatal DDT exposure impairs thermogenesis and the metabolism of carbohydrates and lipids which may increase susceptibility to the metabolic syndrome in adult female offspring.


Subject(s)
DDT/adverse effects , Energy Metabolism/drug effects , Maternal Exposure/adverse effects , Pesticides/adverse effects , Prenatal Exposure Delayed Effects , Adaptation, Physiological/drug effects , Adiposity/drug effects , Animals , Body Composition/drug effects , Cold Temperature , Diet, High-Fat , Dyslipidemias/etiology , Female , Insulin Resistance , Mice , Models, Animal , Pregnancy , Sex Factors
14.
PLoS Genet ; 10(5): e1004335, 2014.
Article in English | MEDLINE | ID: mdl-24874946

ABSTRACT

Fatty liver disease (FLD) is characterized by lipid accumulation in hepatocytes and is accompanied by secretory pathway dysfunction, resulting in induction of the unfolded protein response (UPR). Activating transcription factor 6 (ATF6), one of three main UPR sensors, functions to both promote FLD during acute stress and reduce FLD during chronic stress. There is little mechanistic understanding of how ATF6, or any other UPR factor, regulates hepatic lipid metabolism to cause disease. We addressed this using zebrafish genetics and biochemical analyses and demonstrate that Atf6 is necessary and sufficient for FLD. atf6 transcription is significantly upregulated in the liver of zebrafish with alcoholic FLD and morpholino-mediated atf6 depletion significantly reduced steatosis incidence caused by alcohol. Moreover, overexpression of active, nuclear Atf6 (nAtf6) in hepatocytes caused FLD in the absence of stress. mRNA-Seq and qPCR analyses of livers from five day old nAtf6 transgenic larvae revealed upregulation of genes promoting glyceroneogenesis and fatty acid elongation, including fatty acid synthase (fasn), and nAtf6 overexpression in both zebrafish larvae and human hepatoma cells increased the incorporation of 14C-acetate into lipids. Srebp transcription factors are key regulators of lipogenic enzymes, but reducing Srebp activation by scap morpholino injection neither prevented FLD in nAtf6 transgenics nor synergized with atf6 knockdown to reduce alcohol-induced FLD. In contrast, fasn morpholino injection reduced FLD in nAtf6 transgenic larvae and synergistically interacted with atf6 to reduce alcoholic FLD. Thus, our data demonstrate that Atf6 is required for alcoholic FLD and epistatically interacts with fasn to cause this disease, suggesting triglyceride biogenesis as the mechanism of UPR induced FLD.


Subject(s)
Activating Transcription Factor 6/genetics , Fatty Liver, Alcoholic/genetics , Hepatocytes/metabolism , Transcriptional Activation/genetics , Activating Transcription Factor 6/metabolism , Activating Transcription Factor 6/toxicity , Animals , Animals, Genetically Modified , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Disease Models, Animal , Ethanol/toxicity , Fatty Liver, Alcoholic/etiology , Fatty Liver, Alcoholic/metabolism , Hepatocytes/pathology , Humans , Lipid Metabolism/genetics , Liver/metabolism , Liver/pathology , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Zebrafish
15.
Am J Hum Genet ; 93(6): 1061-71, 2013 Dec 05.
Article in English | MEDLINE | ID: mdl-24268657

ABSTRACT

Obesity is a major public health concern, and complementary research strategies have been directed toward the identification of the underlying causative gene mutations that affect the normal pathways and networks that regulate energy balance. Here, we describe an autosomal-recessive morbid-obesity syndrome and identify the disease-causing gene defect. The average body mass index of affected family members was 48.7 (range = 36.7-61.0), and all had features of the metabolic syndrome. Homozygosity mapping localized the disease locus to a region in 3q29; we designated this region the morbid obesity 1 (MO1) locus. Sequence analysis identified a homozygous nonsense mutation in CEP19, the gene encoding the ciliary protein CEP19, in all affected family members. CEP19 is highly conserved in vertebrates and invertebrates, is expressed in multiple tissues, and localizes to the centrosome and primary cilia. Homozygous Cep19-knockout mice were morbidly obese, hyperphagic, glucose intolerant, and insulin resistant. Thus, loss of the ciliary protein CEP19 in humans and mice causes morbid obesity and defines a target for investigating the molecular pathogenesis of this disease and potential treatments for obesity and malnutrition.


Subject(s)
Cell Cycle Proteins/genetics , Gene Silencing , Obesity, Morbid/genetics , Adult , Amino Acid Sequence , Animals , Cloning, Molecular , Consanguinity , Conserved Sequence , Disease Models, Animal , Female , Gene Order , Gene Targeting , Genetic Association Studies , Genetic Linkage , Genotype , Glucose Tolerance Test , Humans , Insulin/metabolism , Insulin Resistance/genetics , Male , Mice , Mice, Knockout , Molecular Sequence Data , Mutation , Obesity, Morbid/diagnosis , Pedigree , Phenotype , Physical Chromosome Mapping , Signal Transduction , Young Adult
16.
Sci Transl Med ; 5(170): 170ra14, 2013 Jan 30.
Article in English | MEDLINE | ID: mdl-23363978

ABSTRACT

Individuals with a history of binge drinking have an increased risk of developing the metabolic syndrome and type 2 diabetes. Whether binge drinking impairs glucose homeostasis and insulin action is unknown. To test this, we treated Sprague-Dawley rats daily with alcohol (3 g/kg) for three consecutive days to simulate human binge drinking and found that these rats developed and exhibited insulin resistance even after blood alcohol concentrations had become undetectable. The animals were resistant to insulin for up to 54 hours after the last dose of ethanol, chiefly a result of impaired hepatic and adipose tissue insulin action. Because insulin regulates hepatic glucose production and white adipose tissue lipolysis, in part through signaling in the central nervous system, we tested whether binge drinking impaired brain control of nutrient partitioning. Rats that had consumed alcohol exhibited impaired hypothalamic insulin action, defined as the ability of insulin infused into the mediobasal hypothalamus to suppress hepatic glucose production and white adipose tissue lipolysis. Insulin signaling in the hypothalamus, as assessed by insulin receptor and AKT phosphorylation, decreased after binge drinking. Quantitative polymerase chain reaction showed increased hypothalamic inflammation and expression of protein tyrosine phosphatase 1B (PTP1B), a negative regulator of insulin signaling. Intracerebroventricular infusion of CPT-157633, a small-molecule inhibitor of PTP1B, prevented binge drinking-induced glucose intolerance. These results show that, in rats, binge drinking induces systemic insulin resistance by impairing hypothalamic insulin action and that this effect can be prevented by inhibition of brain PTP1B.


Subject(s)
Binge Drinking/pathology , Hypothalamus/drug effects , Hypothalamus/pathology , Insulin Resistance , Insulin/pharmacology , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , Body Weight/drug effects , Female , Glucose/metabolism , Glucose Tolerance Test , Homeostasis/drug effects , Humans , Hypothalamus/metabolism , Inflammation/pathology , Liver/drug effects , Liver/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism , Rats , Signal Transduction/drug effects
17.
J Biol Chem ; 287(39): 33061-9, 2012 Sep 21.
Article in English | MEDLINE | ID: mdl-22810223

ABSTRACT

Insulin controls fatty acid (FA) release from white adipose tissue (WAT) through direct effects on adipocytes and indirectly through hypothalamic signaling by reducing sympathetic nervous system outflow to WAT. Uncontrolled FA release from WAT promotes lipotoxicity, which is characterized by inflammation and insulin resistance that leads to and worsens type 2 diabetes. Here we tested whether early diet-induced insulin resistance impairs the ability of hypothalamic insulin to regulate WAT lipolysis and thus contributes to adipose tissue dysfunction. To this end we fed male Sprague-Dawley rats a 10% lard diet (high fat diet (HFD)) for 3 consecutive days, which is known to induce systemic insulin resistance. Rats were studied by euglycemic pancreatic clamps and concomitant infusion of either insulin or vehicle into the mediobasal hypothalamus. Short term HFD feeding led to a 37% increase in caloric intake and elevated base-line free FAs and insulin levels compared with rats fed regular chow. Overfeeding did not impair insulin signaling in WAT, but it abolished the ability of mediobasal hypothalamus insulin to suppress WAT lipolysis and hepatic glucose production as assessed by glycerol and glucose flux. HFD feeding also increased hypothalamic levels of the endocannabinoid 2-arachidonoylglycerol after only 3 days. In summary, overfeeding impairs hypothalamic insulin action, which may contribute to unrestrained lipolysis seen in human obesity and type 2 diabetes.


Subject(s)
Adipose Tissue, White/metabolism , Dietary Fats/adverse effects , Energy Intake , Hypothalamus/metabolism , Insulin Resistance , Insulin/metabolism , Lipolysis/drug effects , Animals , Diabetes Mellitus, Type 2/metabolism , Dietary Fats/pharmacology , Glucose/metabolism , Glycerol/metabolism , Humans , Male , Obesity/metabolism , Rats , Rats, Sprague-Dawley , Time Factors
18.
Cell Metab ; 13(2): 183-94, 2011 Feb 02.
Article in English | MEDLINE | ID: mdl-21284985

ABSTRACT

White adipose tissue (WAT) dysfunction plays a key role in the pathogenesis of type 2 diabetes (DM2). Unrestrained WAT lipolysis results in increased fatty acid release, leading to insulin resistance and lipotoxicity, while impaired de novo lipogenesis in WAT decreases the synthesis of insulin-sensitizing fatty acid species like palmitoleate. Here, we show that insulin infused into the mediobasal hypothalamus (MBH) of Sprague-Dawley rats increases WAT lipogenic protein expression, inactivates hormone-sensitive lipase (Hsl), and suppresses lipolysis. Conversely, mice that lack the neuronal insulin receptor exhibit unrestrained lipolysis and decreased de novo lipogenesis in WAT. Thus, brain and, in particular, hypothalamic insulin action play a pivotal role in WAT functionality.


Subject(s)
Adipose Tissue, White/metabolism , Brain/metabolism , Insulin/metabolism , Animals , Glucose/metabolism , Lipogenesis , Lipolysis , Male , Mice , Rats , Rats, Sprague-Dawley , Receptor, Insulin/metabolism , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...